enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Women turn to weight loss drugs in menopause: What to know ...

   www.aol.com/women-turn-weight-loss-drugs...

   PHOTO: Semaglutide (GLP-1) weight-loss drug Wegovy, made by pharmaceutical company Novo Nordisk is seen on Oct. 16, 2024. (James Manning/PA Images via Getty Images)

3. This Menopause Side Effect Was Overlooked. Now Doctors Are ...

   www.aol.com/menopause-side-effect-overlooked-now...

   Menopause’s Side Effect ... according to a 2023 review of recent literature on the epidemiology and treatment of eating ... Other experts say that weight loss in menopausal women is almost ...

4. The Terrible—and Amazing—Side Effects of Weight-Loss Drugs

   www.aol.com/terrible-amazing-side-effects-weight...

   GLP-1 drugs used for weight loss involve all kinds of side effects—good and not-so-good—that may or may not strike the average user. (Reminder that there are many of these meds now.

5. Medroxyprogesterone acetate - Wikipedia

   en.wikipedia.org/wiki/Medroxyprogesterone_acetate

   In women, the most common adverse effects of MPA are acne, changes in menstrual flow, drowsiness, and can cause birth defects if taken by pregnant women. Other common side effects include breast tenderness, increased facial hair, decreased scalp hair, difficulty falling or remaining asleep, stomach pain, and weight loss or gain. [24]

6. Tibolone - Wikipedia

   en.wikipedia.org/wiki/Tibolone

   Tibolone can infrequently produce androgenic side effects such as acne and increased facial hair growth. [8] Such side effects have been found to occur in 3 to 6% of treated women. [8] A 2016 Cochrane review has been published on the short-term and long-term effects of tibolone, including adverse effects. [32]

7. Estradiol valerate - Wikipedia

   en.wikipedia.org/wiki/Estradiol_valerate

   Examples of such side effects include breast tenderness and enlargement, nausea, bloating, edema, headache, and melasma. [ 15 ] [ 62 ] High-dose estrogen therapy with estradiol valerate injections may also cause an increased risk of thromboembolism , changes in blood lipid profile , increased insulin resistance , and increased levels of prolactin .